Deerfield Mgmt, L.P. 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:09 pm Sale | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Deerfield Mgmt, L.P. | 1,175,131 4.800% | -630,906 (-34.93%) | Filing |
| 2021-05-07 4:56 pm Purchase | 2021-04-27 | 13G | KalVista Pharmaceuticals, Inc. KALV | Deerfield Mgmt, L.P. | 1,806,037 7.430% | 1,806,037 (New Position) | Filing |